APC and colorectal carcinoma: In this research, we provide strong evidences of activation of EMT and survival factors during initial phases of treatment with DNA damaging agent Camptothecin in Apc floxed colorectal carcinoma model as well as in colorectal/lung carcinoma cell lines.